LPL Financial
TARO

LPL Financial’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

LPL Financial’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,642
Closed -$295K – 4476
2021
Q3 		$295K Buy
4,642
+223
+5% +$15.4K ﹤0.01% 3665
2021
Q2 		$318K Buy
4,419
+97
+2% +$7.13K ﹤0.01% 3548
2021
Q1 		$319K Buy
4,322
+534
+14% +$40.5K ﹤0.01% 3423
2020
Q4 		$278K Sell
3,788
-488
-11% -$31.4K ﹤0.01% 3265
2020
Q3 		$235K Sell
4,276
-96
-2% -$5.97K ﹤0.01% 3089
2020
Q2 		$291K Sell
4,372
-779
-15% -$52.2K ﹤0.01% 2859
2020
Q1 		$315K Sell
5,151
-190
-4% -$14.1K ﹤0.01% 2465
2019
Q4 		$470K Sell
5,341
-139
-3% -$11.7K ﹤0.01% 2430
2019
Q3 		$413K Sell
5,480
-441
-7% -$35.8K ﹤0.01% 2420
2019
Q2 		$506K Buy
+5,921
New +$586K ﹤0.01% 2274
2016
Q2 		– Sell
-2,332
Closed -$340K – 3028
2016
Q1 		$340K Buy
2,332
+476
+26% +$67.6K ﹤0.01% 2418
2015
Q4 		$284K Buy
+1,856
New +$271K ﹤0.01% 2577

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

LPL Financial's TARO Position: Q4 2021 in Review

LPL Financial sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2021, closing a stake of 4,642 shares — an estimated $295K sold.

LPL Financial first reported a position in TARO in Q4 2015 and held it in 12 quarters. The position peaked at $506K in Q2 2019. 71 funds tracked by Wall St. Rank hold TARO as of Q4 2021.

  • LPL Financial reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2021 after selling out during the quarter.
  • LPL Financial sold 4,642 Taro Pharmaceutical Industries Ltd. shares in Q4 2021, an estimated $295K.
  • LPL Financial first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2015 and held it in 12 quarters.
  • LPL Financial's Taro Pharmaceutical Industries Ltd. position peaked at $506K in Q2 2019.
  • 71 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2021.

Based on LPL Financial's 13F filing for Q4 2021, filed 14 Feb 2022.